{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:29:18Z","timestamp":1787902158094,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.physbeh.2010.10.008","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T05:45:27Z","timestamp":1287380727000},"page":"1-6","source":"Crossref","is-referenced-by-count":84,"title":["Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin"],"prefix":"10.1016","volume":"102","author":[{"given":"Li-Tao","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Pan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Cang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2010.10.008_bb0005","unstructured":"http:\/\/www.who.int\/mental_health\/management\/depression\/definition\/en\/."},{"key":"10.1016\/j.physbeh.2010.10.008_bb0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/13543780902880850","article-title":"Current investigational drugs for major depression","volume":"18","author":"Kulkarni","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0015","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","volume":"61","author":"Delgado","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neulet.2006.02.077","article-title":"Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats","volume":"400","author":"Matsuzaki","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1124\/jpet.108.140293","article-title":"Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease","volume":"326","author":"Onozuka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2009.07.081","article-title":"Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation","volume":"1295","author":"Yamamoto","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1254\/jphs.SC0070155","article-title":"Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice","volume":"105","author":"Nakajima","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2007.09.028","article-title":"Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus","volume":"578","author":"Matsuzaki","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1254\/jjp.66.139","article-title":"Pharmacological profile of gastric mucosal protection by marmin and nobiletin from a traditional herbal medicine, Aurantii fructus immaturus","volume":"66","author":"Takase","year":"1994","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pnpbp.2009.02.003","article-title":"Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission","volume":"33","author":"Binfar\u00e9","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2010.05.003","article-title":"Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2, 5-diphenylselenophene: involvement of serotonergic system","volume":"59","author":"Gay","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.brainresbull.2008.08.012","article-title":"Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of Urocortin 3 in a modified forced swimming test in mice","volume":"77","author":"Tanaka","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","article-title":"Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test","volume":"504","author":"Yamada","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0080","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Th\u00e9r"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/YIC.0b013e3283311acd","article-title":"The pharmacological properties of antidepressants","volume":"25","author":"Racagni","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0100","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1586\/14737175.6.11.1741","article-title":"Complementary medicine for depression","volume":"6","author":"Pilkington","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/00006842-199909000-00012","article-title":"Dietary supplements and natural products as psychotherapeutic agents","volume":"61","author":"Fugh-Berman","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bbrc.2005.10.001","article-title":"Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities","volume":"337","author":"Nagase","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","article-title":"Intra and interstrain differences in models of \u201cbehavioral despair\u201d","volume":"70","author":"Bai","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0278-5846(87)90002-9","article-title":"The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs","volume":"11","author":"Steru","year":"1987","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pnpbp.2009.03.004","article-title":"Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system","volume":"33","author":"Machado","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1248\/bpb.26.474","article-title":"Antidepressant-like effects of apigenin and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test","volume":"26","author":"Nakazawa","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2008.10.055","article-title":"Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system","volume":"602","author":"Posser","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","article-title":"Intra and interstrain differences in models of \u201cbehavioral despair\u201d","volume":"70","author":"Bai","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-199905001-00003","article-title":"Antidepressants and the brain","volume":"14","author":"Delgado","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0155","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0160","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.57.8.787","article-title":"Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders","volume":"57","author":"Lambert","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/138945006775515455","article-title":"Serotonin\u2013dopamine interaction as a focus of novel antidepressant drugs","volume":"7","author":"Esposito","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0175","series-title":"Essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl","year":"2000"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-979535","article-title":"The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans","volume":"29","author":"Heninger","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0185","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0306-4522(99)00322-X","article-title":"5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety","volume":"93","author":"Grimaldi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02246053","article-title":"Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists","volume":"119","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(00)00076-7","article-title":"Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims","volume":"99","author":"Rosel","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-3223(90)90440-D","article-title":"5HT2 receptor changes in major depression","volume":"27","author":"Yates","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0210","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1046\/j.1471-4159.1994.62062262.x","article-title":"5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination","volume":"62","author":"Goodnough","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pbb.2010.02.006","article-title":"Involvement of serotonin receptor subtypes in the antidepressant-like effect of trim in the rat forced swimming test","volume":"95","author":"Ulak","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(85)90328-0","article-title":"Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex","volume":"119","author":"Maj","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0225","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s007020070022","article-title":"Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems","volume":"107","author":"Maj","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1471-4159.1999.0720282.x","article-title":"Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides","volume":"72","author":"Garc\u00eda-Sevilla","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0235","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0924-977X(97)00415-X","article-title":"Noradrenaline in basic models of depression","volume":"7","author":"Leonard","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(86)90209-8","article-title":"Chronic antidepressant treatment reduces central beta-adrenoceptor sensitivity in a behavioural test","volume":"127","author":"Handley","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(90)91321-7","article-title":"Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims","volume":"525","author":"De Paermentier","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0250","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-3223(02)01383-5","article-title":"Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study","volume":"52","author":"Klimek","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2007-1014317","article-title":"Anhedonia in schizophrenic, depressed, or alcohol-dependent patients\u2014neurobiological correlates","volume":"27","author":"Heinz","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0260","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00004850-199707003-00002","article-title":"The mesolimbic dopamine system as a target for rapid antidepressant action","volume":"12","author":"Willner","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0028-3908(88)90122-0","article-title":"Enhanced functional responsiveness of the dopaminergic system\u2014the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat","volume":"27","author":"Delini-Stula","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.pharmtox.39.1.313","article-title":"New insights into dopaminergic receptor function using antisense and genetically altered animals","volume":"39","author":"Sibley","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0275","first-page":"89","article-title":"Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats","volume":"54","author":"Ossowska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(95)02131-0","article-title":"Indirect dopamine agonists effects on despair test: dissociation from hyperactivity","volume":"54","author":"Vaugeois","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-9964(01)00185-2","article-title":"Typical antipsychotic drugs \u2014 D(2) receptor occupancy and depressive symptoms in schizophrenia","volume":"56","author":"Bressan","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.physbeh.2010.10.008_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938410003616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938410003616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:29:41Z","timestamp":1740605381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938410003616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0031938410003616"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2010.10.008","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}